1350 related articles for article (PubMed ID: 18463380)
21. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
Cao Y; Liu Q
Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis inhibition in non-GIST soft tissue sarcomas.
Sleijfer S; van der Graaf WT; Blay JY
Oncologist; 2008 Nov; 13(11):1193-200. PubMed ID: 18987047
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.
Lawler PR; Lawler J
Cold Spring Harb Perspect Med; 2012 May; 2(5):a006627. PubMed ID: 22553494
[TBL] [Abstract][Full Text] [Related]
24. Promoting angiogenesis to a fault.
Hicklin DJ
Nat Biotechnol; 2007 Mar; 25(3):300-2. PubMed ID: 17344881
[No Abstract] [Full Text] [Related]
25. Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis.
Tung JJ; Tattersall IW; Kitajewski J
Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006601. PubMed ID: 22355796
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
Jayson G; Armand JP; Berdel WE
Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
[No Abstract] [Full Text] [Related]
27. [Anti-tumor effect of E7080, a novel angiogenesis inhibitor].
Koyama N; Magario N; Yamamoto Y; Matsui J; Tsuruoka A
Nihon Yakurigaku Zasshi; 2008 Aug; 132(2):100-4. PubMed ID: 18689959
[No Abstract] [Full Text] [Related]
28. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
29. Targeting small molecules in cancer.
Wanebo HJ; Berz D; Mega A
Cancer Treat Res; 2007; 135():239-55. PubMed ID: 17953421
[No Abstract] [Full Text] [Related]
30. [Role of receptor tyrosine kinase in the angiogenesis].
Meyer S; Hafner C; Vogt T
Hautarzt; 2002 Sep; 53(9):629-42. PubMed ID: 12432901
[No Abstract] [Full Text] [Related]
31. [Tumor angiogenesis: new approaches to cancer therapy].
Marmé D
Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
[TBL] [Abstract][Full Text] [Related]
32. Targeting angiogenesis in cancer therapy.
Ichihara E; Kiura K; Tanimoto M
Acta Med Okayama; 2011 Dec; 65(6):353-62. PubMed ID: 22189475
[TBL] [Abstract][Full Text] [Related]
33. Role of VEGF-flt receptor system in normal and tumor angiogenesis.
Shibuya M
Adv Cancer Res; 1995; 67():281-316. PubMed ID: 8571818
[No Abstract] [Full Text] [Related]
34. Angiogenesis: now and then.
Costa C; Soares R; Schmitt F
APMIS; 2004; 112(7-8):402-12. PubMed ID: 15563305
[TBL] [Abstract][Full Text] [Related]
35. VEGF receptor signaling in tumor angiogenesis.
McMahon G
Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
[TBL] [Abstract][Full Text] [Related]
36. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
Joussen AM; Kirchhof B; Gottstein C
Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
[TBL] [Abstract][Full Text] [Related]
37. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer C; Mazzone M; Jonckx B; Carmeliet P
Nat Rev Cancer; 2008 Dec; 8(12):942-56. PubMed ID: 19029957
[TBL] [Abstract][Full Text] [Related]
38. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
39. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor as a target for anticancer therapy.
Ferrara N
Oncologist; 2004; 9 Suppl 1():2-10. PubMed ID: 15178810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]